Originator and biosimilar market dynamics

Research output: Contribution to conferenceKeynote

160 Downloads (Pure)


There is growing expenditure on medicines worldwide, estimated to reach US$1.5 trillion by 2023, with implications for affordability even in high income countries. This increase is driven by biological medicines for complex diseases, including cancer and orphan diseases , which are becoming unaffordable. The costs even for the anti TNFs has resulted in their limited prescribing among a number of Central and Eastern European countries, which is difficult to sustain. Biosimilars offer a way forward to improve the care of patients with proven similar effectiveness and safety between originators and biosimilars, e.g. NOR SWITCH study in Norway.
Original languageEnglish
Number of pages27
Publication statusPublished - 25 Aug 2021
EventBiosimilars Latam - Brazil 2021 - Online Event, Brazil
Duration: 25 Aug 202126 Aug 2021


ConferenceBiosimilars Latam - Brazil 2021


  • biosimilars
  • biological medicines
  • affordable medication
  • prescribing behaviours


Dive into the research topics of 'Originator and biosimilar market dynamics'. Together they form a unique fingerprint.

Cite this